Sarepta plunges after death linked to Elevidys
Source: SeekingAlpha
2025-03-18 08:17:17 ET
More on Sarepta, Roche, etc.
- Roche And Zealand Team Up To Develop Petrelintide
- Sarepta Therapeutics' Long-Term Potential Intact Despite Near-Term Stock Weakness
- Sarepta Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation
- FDA commissioner nominee Makary advances to full Senate vote
- Roche-Zealand deal is the latest to boost obesity space
Read the full article on Seeking Alpha
For further details see:
Sarepta plunges after death linked to Elevidys
Centurion Acquisition Corp.
NASDAQ: ALF
ALF Trading
0.0% G/L:
$10.77 Last:
6,212 Volume:
$10.72 Open:
